•   EN

    • Increase the success rate for

    fertility clinics in IVF treatments 

    NON-INVASIVT PGT-A
    Non- invasive PGT-A is a genetic screening method for fertilized eggs (blastocysts) grown in connection with an IVF treatment.

    Non- invasive PGT-A is used to examine which eggs (blastocysts) have a normal number of chromosomes (euploid, 46 chromosomes), and which eggs (blastocysts) have an abnormal number of chromosomes (aneuploid, 45 or 47 chromosomes).

    The method will help the fertility doctor to select the most suitable eggs (blastocysts) for implantation.  Non-invasive PGT-A selects blastocysts to increase the chances of getting pregnant faster in IVF treatment.

    HOW IS THE METHOD NON-INVASIVE?

    • A fertilized egg (blastocyst) naturally releases free DNA to the liquid.
    • The egg is transferred to a new and pure liquid to be preserved in the clinic.
    • The free DNA in the original liquid will be used to perform niPGT-A

     

    OUR RESULTS:

    • 35% of fertilized eggs analyzed with niPGT-A have chromosomal abnormalities known as aneuploids.
    • 56% of the fertilized eggs analyzed with niPGT-A were determined free of chromosomal abnormalities known as euploid, this produces greater chances of success in IVF

    ANEUPPLOIDRATE

    AGE DISTRIBUTION OF ANEUPLOIDY

    More aneuploid eggs will be found as the woman’s age increase. With niPGT-A we reduce IVF treatment time by helping fertility clinics select healthy eggs, free of abnormalities and with a high implantation potential. Instead of 2 or more treatments, fertility clinics can reduce to a single IVF

    OTHER STUDIES:

    National Summary Report: with niPGT-A there is an increased chance of pregnancy and delivery in women of different age groups. 

    Reference: (sartcorsonline.com)

    BIOPSY FREE & GENTLE = The new niPGT-A

    No damage - non-invasive.

    niPGT-A BENEFITS

    • niPGT-A makes it possible to analyze all the fertilized eggs (blastocysts) in connection with an IVF treatment.
    • niPGT-A helps fertility doctors prioritize the fertilized eggs (blastocysts) with the highest implantation potential.
    • niPGT-A is performed non-invasively and is therefore 100% safe and damage to the fertilized eggs is completely avoided in connection with sampling.
    • niPGT-A increases the rate of pregnancy in an IVF course, as only euploid eggs (blastocysts) will be used for implantation. niPGT-A can reduce the time to get successfully pregnant.


    WE RECOMMEND THIS TEST IF:

    • You are doing an in vitro fertilization treatment.
    • After several unsuccessful in vitro treatments.
    • You have decided to preserve eggs at a fertility clinic for a future pregnancy.

    HOW TO DO IT?

     





    Join our network of clinics and offer the best treatment for your patient